Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

ABT-751 With Chemotherapy for Relapsed Pediatric ALL

This study has been terminated.
(The study was stopped due to poor accrual and lack of funding.)
Sponsor:
Information provided by (Responsible Party):
Therapeutic Advances in Childhood Leukemia Consortium
ClinicalTrials.gov Identifier:
NCT00439296
First received: February 21, 2007
Last updated: November 28, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)